cpc 1 jan 12 2008 dr ruenger
TRANSCRIPT
-
8/8/2019 CPC 1 Jan 12 2008 Dr Ruenger
1/92
CPC
Supervisor
Dr. Thomas Ruenger
Jan. 12, 2009
Muhammad Khawar Nazir
-
8/8/2019 CPC 1 Jan 12 2008 Dr Ruenger
2/92
Case 1
-
8/8/2019 CPC 1 Jan 12 2008 Dr Ruenger
3/92
Picture 1/4
-
8/8/2019 CPC 1 Jan 12 2008 Dr Ruenger
4/92
Picture 2/4
-
8/8/2019 CPC 1 Jan 12 2008 Dr Ruenger
5/92
Picture 3/4
-
8/8/2019 CPC 1 Jan 12 2008 Dr Ruenger
6/92
Picture 4/4
-
8/8/2019 CPC 1 Jan 12 2008 Dr Ruenger
7/92
-
8/8/2019 CPC 1 Jan 12 2008 Dr Ruenger
8/92
-
8/8/2019 CPC 1 Jan 12 2008 Dr Ruenger
9/92
Verocay body of a neurilemoma, consisting of tight, discrete
aggregates of spindle-shaped, palisaded nuclei with a central
fibrillary area, representing collections of cytoplasmic
processes of tumorous Schwann cells
-
8/8/2019 CPC 1 Jan 12 2008 Dr Ruenger
10/92
Hypercellular areas often show nuclear palisading and Verocay
bodies.
-
8/8/2019 CPC 1 Jan 12 2008 Dr Ruenger
11/92
Schwannoma "Neurilemmoma
Tumor originating from the Schwann cells
Myelin sheath which covers peripheral nerves isproduced by the Schwann cells
Tumor cells always stay on the outside of the nerve
Relatively slow growing
-
8/8/2019 CPC 1 Jan 12 2008 Dr Ruenger
12/92
Schwannoma "Neurilemmoma
Mostly benign and less than 1% become malignant known asmalignant peripheral nerve sheath tumour or malignant
Schwannoma or neurofibrosarcoma
Schwannomas can arise from a genetic disorder calledneurofibromatosis
Schwannomas can be removed surgically, but can then recur
-
8/8/2019 CPC 1 Jan 12 2008 Dr Ruenger
13/92
A solid lesion arises within a nervecomposed of a single fascicle
The tumor is composed of Schwann cell
proliferation within the epineurium andperipherallydisplaced nerve fibers,resulting in nodular eccentric growth
No capsule is formed in the early growthphase
The larger tumor (bottom) slightlyincreases the size of the parent nerve andeventually becomes separated fromsurrounding fascicles by a capsule formedfrom the perineurium and epineurium.Occasional axons are present.
-
8/8/2019 CPC 1 Jan 12 2008 Dr Ruenger
14/92
HistopatholgyAntoni A & Antoni B Tissues
Encapsulated subcutaneous tumor
with
1) Cellular areas ( Antoni A tissue )
and / or
2)Edematous myxoid areas (Antoni B tissue)
-
8/8/2019 CPC 1 Jan 12 2008 Dr Ruenger
15/92
-
8/8/2019 CPC 1 Jan 12 2008 Dr Ruenger
16/92
Vecoray Bodies
Spindle cells in Antoni A tissue line up in twoparallel rows separated by areas without
nuclei
-
8/8/2019 CPC 1 Jan 12 2008 Dr Ruenger
17/92
-
8/8/2019 CPC 1 Jan 12 2008 Dr Ruenger
18/92
Case 2
-
8/8/2019 CPC 1 Jan 12 2008 Dr Ruenger
19/92
Picture 1/6
-
8/8/2019 CPC 1 Jan 12 2008 Dr Ruenger
20/92
Picture 2/6
-
8/8/2019 CPC 1 Jan 12 2008 Dr Ruenger
21/92
Picture 3/6
-
8/8/2019 CPC 1 Jan 12 2008 Dr Ruenger
22/92
Picture 4/6
-
8/8/2019 CPC 1 Jan 12 2008 Dr Ruenger
23/92
Picture 5/6
-
8/8/2019 CPC 1 Jan 12 2008 Dr Ruenger
24/92
Picture 6/6
-
8/8/2019 CPC 1 Jan 12 2008 Dr Ruenger
25/92
-
8/8/2019 CPC 1 Jan 12 2008 Dr Ruenger
26/92
-
8/8/2019 CPC 1 Jan 12 2008 Dr Ruenger
27/92
-
8/8/2019 CPC 1 Jan 12 2008 Dr Ruenger
28/92
-
8/8/2019 CPC 1 Jan 12 2008 Dr Ruenger
29/92
Kaposi Sarcoma
Controversial whether Kaposi's sarcoma (KS) representsneoplasia or hyperplasia;
All clinical variants are viewed as a virally induced disease
human herpesvirus-8 (HHV-8) is the implicated agent
Multifocal systemic disease with 4 principal clinicalvariants:
(1) chronic or classic KS;
(2) African endemic KS, including a fulminantlymphadenopathic type;
(3) KS in iatrogenically immunocompromised patients; and
(4) AIDS-related epidemic KS
-
8/8/2019 CPC 1 Jan 12 2008 Dr Ruenger
30/92
Key Features
Cutaneous lesions present as variably distributed pink patches,blueviolet to black nodules or plaques, and polyps, depending onthe clinical variant and stage
The histologic appearance of KS does not vary significantly
between clinical subtypes, but does vary with stage of the lesion
Most cases in childhood, with or without HIV infection, are of thelymphadenopathic type and are rapidly fatal due to visceraldissemination
Because of multifocality, treatment with chemotherapy and/orradiation is favored over surgery
-
8/8/2019 CPC 1 Jan 12 2008 Dr Ruenger
31/92
Kaposi's sarcoma
Tumor caused byHuman herpesvirus 8
(HHV8), also known as Kaposi's sarcoma-
associated herpesvirus (KSHV)
It was originally described by Moritz Kaposi, a
Hungarian dermatologist practicing at the
University of Vienna in 1872
-
8/8/2019 CPC 1 Jan 12 2008 Dr Ruenger
32/92
Kaposi sarcoma
KS is a neoplasm that often manifests withmultiple vascular nodules in the skin and otherorgans.
Although true metastases appear to occur, a
multifocal origin is most common. The pattern of KS is variable, with a course
ranging from indolent (only skin manifestations)to fulminant (extensive visceral involvement).
KS also may arise primarily in the oral mucosa,lymph nodes, and/or viscera without skininvolvement.
KS initially may be evident in any organ of thebody
-
8/8/2019 CPC 1 Jan 12 2008 Dr Ruenger
33/92
3 FORMS
1)Localized nodular
2)Locally aggressive3)Generalized
-
8/8/2019 CPC 1 Jan 12 2008 Dr Ruenger
34/92
6 stages
1. Patch
2. Plaque
3. Nodular4. Exophytic
5. Infiltrative
6. Lymphadenopathic
-
8/8/2019 CPC 1 Jan 12 2008 Dr Ruenger
35/92
Differential Diagnoses
1. BacillaryAngiomatosis
2. Blue Rubber Bleb Nevus Syndrome3. Nevi, Melanocytic
4. Pyogenic Granuloma (Lobular Capillary
Hemangioma)5. Tufted Angioma
-
8/8/2019 CPC 1 Jan 12 2008 Dr Ruenger
36/92
Histopathology
Slitlike spaces
Vessels sometimes appear as lymphangiomatosis,
without erythrocytes
Promontory sign
small blood vessel and its stroma project like a
promontory into a vascular space.
-
8/8/2019 CPC 1 Jan 12 2008 Dr Ruenger
37/92
Treatment
Surgical excision,
Radiotherapy
Intralesional Outpatient low-dose vinblastine
chemotherapy
Radiotherapy Laser
-
8/8/2019 CPC 1 Jan 12 2008 Dr Ruenger
38/92
Case 3
-
8/8/2019 CPC 1 Jan 12 2008 Dr Ruenger
39/92
Picture 1/5
-
8/8/2019 CPC 1 Jan 12 2008 Dr Ruenger
40/92
Picture 2/5
-
8/8/2019 CPC 1 Jan 12 2008 Dr Ruenger
41/92
Picture 3/5
-
8/8/2019 CPC 1 Jan 12 2008 Dr Ruenger
42/92
Picture 4/5
-
8/8/2019 CPC 1 Jan 12 2008 Dr Ruenger
43/92
Picture 5/5
-
8/8/2019 CPC 1 Jan 12 2008 Dr Ruenger
44/92
-
8/8/2019 CPC 1 Jan 12 2008 Dr Ruenger
45/92
-
8/8/2019 CPC 1 Jan 12 2008 Dr Ruenger
46/92
-
8/8/2019 CPC 1 Jan 12 2008 Dr Ruenger
47/92
-
8/8/2019 CPC 1 Jan 12 2008 Dr Ruenger
48/92
-
8/8/2019 CPC 1 Jan 12 2008 Dr Ruenger
49/92
Porphyria
Uncommon to rare group of porphyrin
metabolidsm disorders
Most of them present as photodermatitis with
papules or vesicles mostly on sun exposed skin
Acute and Non Acute Types
-
8/8/2019 CPC 1 Jan 12 2008 Dr Ruenger
50/92
Porphyria Cutanea Tarda
Tarda means Late ( adult onset)
Non Acute Type
Most common type of porphyria. It results from a
decreased catalytic activity of uroporphyrinogendecarboxylase, the fifth enzyme in heme biosynthesis
Cutaneous Manifestations : increased photosensitivity andskin fragility as well as blistering, erosions, crusts, milia and
scars in sun-exposed sites
Postinflammatory hyperpigmentation, hypertrichosis,scarring alopecia, and morpheaform and sclerodermoidchanges can be observed
-
8/8/2019 CPC 1 Jan 12 2008 Dr Ruenger
51/92
-
8/8/2019 CPC 1 Jan 12 2008 Dr Ruenger
52/92
Types
Depending upon the major site of expression of the
uroporphyrinogen decarboxylase, at least 2 types canbe distinguished:
1) Sporadic (acquired) variant, designated type I PCT, inwhich the enzymatic deficiency is exclusively expressedin the liver
2) Autosomal dominant familial (hereditary) variant,designated type II PCT, in which the catalytic enzymaticdefect is detected in all tissues
-
8/8/2019 CPC 1 Jan 12 2008 Dr Ruenger
53/92
Histologic & Immunofluorescence Microscopy Findings
Subepidermal blister with a minimal cell-poor dermalinflammatory infiltrate
Festooning of the dermal papillae (very well preservedpapillae projecting into blister ) with PAS-positivedeposits within the walls of blood vessels (PAS stain)
Direct immunofluorescence with prominent ring-shaped staining around blood vessels and lesser linearstaining along the dermalepidermal junction.
Diff ti l Di i
-
8/8/2019 CPC 1 Jan 12 2008 Dr Ruenger
54/92
Differential Diagnosis
Other types of cutaneous porphyria that manifesting blistering,
Mild variants of congenital erythropoietic porphyria
Hepatoerythropoietic porphyria
Variegate porphyria
Hereditary coproporphyria.
Pseudoporphyria
Epidermolysis bullosa acquisita
Polymorphous light eruption
Phototoxic and bullous drug eruptions
Hydroa vacciniforme
All above diseases can easily be differentiated from PCT bymeasuring urinary and stool porphyrins
-
8/8/2019 CPC 1 Jan 12 2008 Dr Ruenger
55/92
Therapeutic Approaches
1. Photoprotection, e.g. broad-spectrum sunscreens and/orprotective clothing
2. Avoidance of sunlight exposure and trauma
3. Cease alcohol ingestion; stop estrogen therapy
4. Phlebotomy: 400500 ml every 2 weeks over 3 to 6 months
5. Low-dose hydroxychloroquine or chloroquine
6. Measurement of urinary porphyrin excretion to monitortherapeutic outcome
-
8/8/2019 CPC 1 Jan 12 2008 Dr Ruenger
56/92
Case 4
-
8/8/2019 CPC 1 Jan 12 2008 Dr Ruenger
57/92
Picture 1/6
-
8/8/2019 CPC 1 Jan 12 2008 Dr Ruenger
58/92
Picture 2/6
-
8/8/2019 CPC 1 Jan 12 2008 Dr Ruenger
59/92
Picture 3/6
-
8/8/2019 CPC 1 Jan 12 2008 Dr Ruenger
60/92
Picture 4/6
-
8/8/2019 CPC 1 Jan 12 2008 Dr Ruenger
61/92
Picture 5/6
-
8/8/2019 CPC 1 Jan 12 2008 Dr Ruenger
62/92
Picture 6/6
-
8/8/2019 CPC 1 Jan 12 2008 Dr Ruenger
63/92
-
8/8/2019 CPC 1 Jan 12 2008 Dr Ruenger
64/92
-
8/8/2019 CPC 1 Jan 12 2008 Dr Ruenger
65/92
-
8/8/2019 CPC 1 Jan 12 2008 Dr Ruenger
66/92
Leishmaniasis
Synonyms:
Old World cutaneous leishmaniasis: oriental sore, Delhi
boil, Baghdad boil
New World cutaneous and mucocutaneousleishmaniasis: chiclero's ulcer (Mexico), uta and espundia(Peru), ulcera de Bauru (Brazil), bush or forest yaws, pian
boi (Guyanas)
Visceral leishmaniasis: kala-azar and Dumdum fever
-
8/8/2019 CPC 1 Jan 12 2008 Dr Ruenger
67/92
Leishmaniasis
Chronic parasitic (protozoan) disease in whichorganisms are found within phagolysosomes of themononuclear phagocyte system
Most common cutaneous finding is a papule thatdevelops at the site of inoculation and then enlarges andulcerates
Vector is a sandfly infected with promastigotes
Worldwide distribution, but endemic in LatinAmerica, the Mediterranean basin, and parts ofAsia andAfrica
-
8/8/2019 CPC 1 Jan 12 2008 Dr Ruenger
68/92
Sand Fly
-
8/8/2019 CPC 1 Jan 12 2008 Dr Ruenger
69/92
Life cycle of the Leishmania parasite
-
8/8/2019 CPC 1 Jan 12 2008 Dr Ruenger
70/92
Leishmaniasis
Leishmaniasis encompasses a spectrum ofchronic infections in humans and several animalspecies
It is caused byover 15 species ofLeishmania,flagellated protozoans belonging to the orderKinetoplastidae
Transmission is via the bite of sandflies from thegenera Phlebotomus and Lutzomyia.
-
8/8/2019 CPC 1 Jan 12 2008 Dr Ruenger
71/92
Clinical Features
Begins as a small, well-circumscribed papule at theinoculation site that may enlarge into a nodule orplaque and then become ulcerated or verrucous
Exposed sites are most commonly involved
Lesions are often solitary but they may be multiple,with the formation of satellites or lymphatic spread
Majority of acute cutaneous infections resolvespontaneously with scarring but some may becomechronic or disseminated.
-
8/8/2019 CPC 1 Jan 12 2008 Dr Ruenger
72/92
Histopatholgy
Epidermis normal, atrophic, hyperplastic, or
ulcerated
Diffuse mixed granulomatous dermal infiltrateof lymphocytes, histiocytes, plasma cells,
neutrophils, and multinucleated giant cells
Occasional caseational necrosis
Fibrosis in older lesions
-
8/8/2019 CPC 1 Jan 12 2008 Dr Ruenger
73/92
Diagnosis
Diagnosis can be confirmed by demonstrating the
presence ofAmastigotes in dermal macrophages
byskin biopsy, dermal scrapings or fine-needle
aspiration
Giemsa, Wright or Feulgen stains are used to
demonstrate the organisms in smears and tissue:the cytoplasm appears blue, the nucleus pink and
the kinetoplast a deep red
-
8/8/2019 CPC 1 Jan 12 2008 Dr Ruenger
74/92
Differential Diagnosis
Persistent arthropod bites
Basal cell carcinomas
Atypical mycobacterioses
Mucocutaneous leishmaniasis can resemble otherinfections such as paracoccidioidomycosis, nomaand tertiary syphilis
In addition, Wegener's granulomatosis andangiocentric NK/T-cell lymphoma must beconsidered when ulcerative mucocutaneouslesions affect the central part of the face
-
8/8/2019 CPC 1 Jan 12 2008 Dr Ruenger
75/92
Treatment
Pentavalent antimonials - Standard therapy
for New World leishmaniasis as well as more
severe cutaneous infections
Additional therapies :
Heat therapy, Cryotherapy, Pentamidine,
Itraconazole, Amphotericin B, Ketoconazole,
Allopurinol
-
8/8/2019 CPC 1 Jan 12 2008 Dr Ruenger
76/92
Prevention
Use ofinsect repellants and insecticides, as
well as the destruction of animal reservoirs
Akilled L. amazonensis promastigote vaccine
has been shown to induce a Th1 response andsignificant resistance against Leishmania
-
8/8/2019 CPC 1 Jan 12 2008 Dr Ruenger
77/92
Case 5
-
8/8/2019 CPC 1 Jan 12 2008 Dr Ruenger
78/92
Picture 1/4
-
8/8/2019 CPC 1 Jan 12 2008 Dr Ruenger
79/92
Picture 2/4
-
8/8/2019 CPC 1 Jan 12 2008 Dr Ruenger
80/92
Picture 3/4
-
8/8/2019 CPC 1 Jan 12 2008 Dr Ruenger
81/92
Picture 4/4
-
8/8/2019 CPC 1 Jan 12 2008 Dr Ruenger
82/92
-
8/8/2019 CPC 1 Jan 12 2008 Dr Ruenger
83/92
-
8/8/2019 CPC 1 Jan 12 2008 Dr Ruenger
84/92
Venous Lake
First described in 1956 by Bean and Walsh, whonoted how they can be easily compressed and theirtendency to occur on sun-exposed skin, especiallythe ears of elderly
Also known as "Phlebectases" is an asymptomatic ,generally solitary, soft, compressible, dark blue toviolaceous, 0.2- to 1-cm papule
Commonly found on sun-exposed surfaces of thevermilion border of the lip, face and ears
Lesions generally occur among the elderly
-
8/8/2019 CPC 1 Jan 12 2008 Dr Ruenger
85/92
Importance
ClinicallyInsignificant from a biological
standpoint
Important because of their mimicry of more
ominous lesions, such as Melanoma and
Pigmented Basal Cell Carcinoma.
-
8/8/2019 CPC 1 Jan 12 2008 Dr Ruenger
86/92
Venous Lake
Though these lesions may resemble nodularmelanoma , the lack of induration, slowgrowth, and lightening appearance upon
diascopy suggest against it, and indicate avascular lesion
Additionally, lack of pulsation distinguishesthis lesion of the lower lip from a tortuoussegment of the inferior labial artery
-
8/8/2019 CPC 1 Jan 12 2008 Dr Ruenger
87/92
Etiology
Unknown; however it is thought to be associated withsun exposure and sun damage, leading to a dilatedblood-filled vascular channel
One theory is that chronic solar damage injures thevascular adventitia and the dermal elastic tissue,permitting dilatation of superficial venous structures.
"...lined with a singled layer of flattened endothelialcells and a thin wall of fibrous tissue filled with redblood cells."
-
8/8/2019 CPC 1 Jan 12 2008 Dr Ruenger
88/92
Differential Diagnosis
Angiokeratoma Circumscriptum
Lentigo
Basal Cell Carcinoma
Malignant Melanoma Blue Nevi
Nevi, Melanocytic
CherryHemangioma
Pyogenic Granuloma (Lobular CapillaryHemangioma) Kaposi Sarcoma
-
8/8/2019 CPC 1 Jan 12 2008 Dr Ruenger
89/92
Work Up
Diascopy
Dermoscopy
Biopsy, If diagnosis is uncertain
Histologic Findings
-
8/8/2019 CPC 1 Jan 12 2008 Dr Ruenger
90/92
Histologic Findings Single large dilated space or several interconnecting dilated
spaces characteristically are observed in the superficial dermis
Dilated channels have very thin walls that are lined by a singlelayer of flattened endothelium and supported by a thin layerof fibrous connective tissue
Usually, no smooth muscle or elastic tissue is found in thevessel wall
In rare cases, a thin and noncircumferential area suggestive ofsmooth muscle can be found instead of the fibrous tissue
Solar elastosis and other evidence ofsun damage usually arefound in the adjacent dermis.
-
8/8/2019 CPC 1 Jan 12 2008 Dr Ruenger
91/92
Treatment
Not necessary, and patients should be
reassured of the lesion's non-malignant
nature
However, if treatment is sought for cosmetic
reasons, lesions can be treated with surgical
excision, laser therapy, infrared coagulation,cryotherapy and sclerotherapy
-
8/8/2019 CPC 1 Jan 12 2008 Dr Ruenger
92/92
Thank you